Another Windows Partner Bashes Microsoft's Confusing Strategy

There's been a recurring theme among hardware OEMs over the past six months regarding both of Microsoft's (NASDAQ: MSFT  ) new Windows platforms. The broad consensus among the software giant's most important partners is that Windows 8 and Windows RT are just too confusing for the average consumer.

In December, Dell (NASDAQ: DELL  ) PC exec Jeffrey Clarke said he made the case directly to Steve Ballmer that Windows RT would do nothing but confuse people, since the Windows brand is associated with backwards compatibility with legacy apps. Dell sells tablets running each version, such as its XPS 10 (Windows RT) and Latitude 10 (Windows 8).

5 Best Machinery Stocks To Buy For 2015

A month later, Acer CEO JT Wang similarly said that Windows 8 confuses consumers, and that Microsoft's big push with Surface is just making things worse. Wang said that "there's no question" that the platform is off to a "slow start." Samsung was next up, saying it wouldn't launch Windows RT devices in the U.S. because it would need to take on a lot of educational efforts to prevent confusion.

Dell and Acer are the No. 3 and No. 4 PC vendors in the world by volume, respectively, so they should know how sales are going. Let's add in another PC vendor that thinks Microsoft is going about this all wrong.

Toshiba is the latest OEM to call Microsoft's strategy confusing. Australian exec Mark Whittard derided the software giant for offering too many different choices that have led to "a lot of confusion with Windows 8," according to The Australian. The comments are curious since Whittard was speaking at a product launch, which included over two dozen models of Ultrabooks, tablets, and convertibles.

Whittard also said the pricing wasn't clear. Most previous-generation laptops were selling for $399 to $599, but the newest Windows 8 gadgets start between $699 and $799 -- making it an even tougher sell.

For what it's worth, Microsoft is taking notes. At the Wired Business Conference, Windows exec Julie Larson-Green conceded that Windows RT's biggest problem has been education. Consumers and OEMs alike have spoken, now Microsoft needs to either ramp up the education or kill Windows RT for good once Intel's Haswell chips render it even more unnecessary.

Microsoft should probably do the latter.

It's been a frustrating path for Microsoft investors, who've watched the company fail to capitalize on the incredible growth in mobile over the past decade. However, with the release of its own tablet, along with the widely anticipated Windows 8 operating system, the company is looking to make a splash in this booming market. In a new premium report on Microsoft, a Motley Fool analyst explains that while the opportunity is huge, so are the challenges. The report includes regular updates as key events occur, so make sure to claim a copy of this report now by clicking here.

5 Best Casino Stocks To Watch Right Now

5 Best Casino Stocks To Watch Right Now: MGM Resorts International(MGM)

MGM Resorts International, through its subsidiaries, primarily owns and operates casino resorts in the United States. The company?s resorts offer gaming, hotel, dining, entertainment, retail, and other resort amenities. It also owns and operates golf courses and a golf club. As of December 31, 2010, the company owned and operated 15 properties located in Nevada, Mississippi, and Michigan; and has 50% investments in 4 other casino resorts in Nevada, Illinois, and Macau. In addition, MGM Resorts International has an agreement with the Mashantucket Pequot Tribal Nation, which owns and operates a casino resort in Connecticut, to carry the ?MGM Grand? brand name. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

Advisors' Opinion:

• [By Bradley Seth McNew]

  Wynn Resorts has a dividend yield of 4.1%, the highest in the industry, ahead of the next closest Las Vegas Sands (NYSE: LVS  ) , at 3.5%, and MGM Resorts International (NYSE: MGM  ) , which doesn't pay a dividend. Wynn management has been steadily raising dividend payouts since 2010, and has consistently paid special dividends during the past five years. All of this looks great for Wynn as a dividend buy. However, the special dividend paid this year is far below that of previous years, and the high payout ratio, at around 95%, according to Yahoo! Finance, may not be sustainable as Wynn continues to struggle to maintain growth. Here are the two things dividend investors need to know before investing in Wynn based on its dividend.

• [By Bradley Seth McNew]

  Macau's gambling market has definitely seen less spectacular results this year than last. The major gambling companies ! there, including Las Vegas Sands (NYSE: LVS  ) , MGM Resorts International (NYSE: MGM  ) , Wynn Resorts (NASDAQ: WYNN  ) , and Melco Crown (NASDAQ: MPEL  ) , have each felt the sting of lowered gross gambling revenue on the Chinese island during the past two quarters as the VIP segment of gamblers has declined there.

• [By Bradley Seth McNew]

  Las Vegas Sands (NYSE: LVS  ) has been the leader in its industry by a wide margin for the last few quarters when it comes to revenue and earnings, both actual and percent growth year over year. In Q2, Las Vegas Sands led the industry. It came in ahead of Wynn Resorts (NASDAQ: WYNN  ) and MGM Resorts International (NYSE: MGM  ) in earnings, just as it did in Q1 and throughout 2013. While Sands is the only one to have reported Q3 earnings so far, I expect its income growth will beat that of MGM and Wynn.
  

source from Top Stocks For 2015:http://www.topstocksblog.com/5-best-casino-stocks-to-watch-right-now-2.html

Top 5 Consumer Service Companies To Buy Right Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of iRobot (NASDAQ: IRBT  ) were falling apart today, down as much as 15% following disappointing guidance in its earnings report.

So what: The maker of the Roomba and other automated machines said that adjusted earnings per share came in at $0.21, beating estimates of $0.19, while it also topped revenue projections of $128.9 million as sales grew 17% to $130.4 million. Management credited growth in the Home Robot segment for the strong quarter and noted expansion in Brazil and a new partnership with Cisco Systems called Enterprise Telepresence. Still, analysts seemed to be disappointed by current quarter EPS guidance of $0.20-$0.25, below estimates at $0.27.

Now what: Wall Street often punishes companies for delivering poor guidance after beating estimates, and this is no exception. iRobot did raise the lower end of its full-year EPS range to $0.88 from $0.80, because of a one-time tax benefit, with the high end at $1.00, but that's only enough to make the analyst consensus of $0.94 the midpoint. I'd tend to ignore today's drop in the stock as this was a strong quarter, and the pullback seems to be mostly valuation-based as the P/E is still lofty at 37. Long-term investors should be satisfied with a report like this.

Top 5 Financial Stocks To Buy For 2015: Cree Inc.(CREE)

Cree, Inc. develops and manufactures light emitting diodes (LEDs), LED lighting, and semiconductor solutions for wireless and power applications. Its LED products include blue and green LED chips that are used in various applications, including video screens, gaming displays, function indicator lights, and automotive backlighting; LED components comprising a range of packaged LED products and LED modules for lighting applications; LED lighting products, such as LED downlights, LED troffers, and LED lamps or bulbs for construction, retrofit, and renovation projects in commercial, governmental, and residential applications; and silicon carbide (SiC) wafers, which are used in the manufacture of optoelectronics, microwave, power switching, and other applications. The company also provides semiconductor materials and devices primarily based on silicon carbide (SiC), gallium nitride (GaN), and related compounds. Its power and radio frequency (RF) products include SiC-based power products comprising 600, 1,200, and 1,700-volt Schottky diodes, as well as 1,200-volt SiC metal semiconductor field-effect transistor switches that are used in power factor correction circuits for power supplies in computer servers and other applications, such as solar inverters; and RF devices, including a range of GaN high electron mobility transistors and monolithic microwave integrated circuits for military or commercial applications, as well as 10 watt and 60 watt SiC transistors and metal semiconductor field effect transistor products. The company primarily operates in China, the United States, Europe, South Korea, Japan, Malaysia, and Taiwan. Cree, Inc. was formerly known as Cree Research, Inc. and changed its name in January 2000. Cree, Inc. was founded in 1987 and is based in Durham, North Carolina.

Advisors' Opinion:

• [By Stock Investor]

  Next up I will look at SemiLEDs Corporation (LEDS). This company is based in China, typically a red flag from the start. In the last year LEDS posted almost $26m in revenue with a net cash balance of approximately $36m. The market cap here is a small $42m, much cheaper than RVLT. LEDS has an average quarterly cash burn of about $5m, leaving them ample funding for the next two years at current spend rates. So far the financials here suggest that LEDS is undervalued, especially when compared to RVLT. Usually, however where there is smoke there is fire. In 2012 LEDS lost a patent infringement suit against CREE Inc (CREE). The settlement prevents LEDS from selling it product in the US, a major red flag. This is also the likely reason for such a large drop in sales over the last year of almost 40%. Revenue for the second quarter of fiscal 2013 was $4.8 million, a 39% decrease compared to $7.9 million in the second quarter of fiscal 2012. It is disconcerting that a company in a sector that is supposedly experiencing record growth, is seeing its sales drop this much. A major red flag for investors. While the cash position is a positive, investors should note that this is a China based company. Accurate financials are not something Chinese companies are know for.

• [By Lee Jackson]

  Cree Inc. (NASDAQ: CREE) was buried as light emitting diode (LED) sales had stumbled due to overcapacity. The company also overproduced some radio frequency (RF) semiconductor parts and had to slow production at one point to almost a standstill. A resilient housing and automobile market turned the market around and the stock went on a tear. The consensus price target is posted at a stunning $70.

• [By Garrett Cook]

  Cree (NASDAQ: CREE) shares were also up, gaining 3.94 percent to $52.29. Oppenheimer upgraded Cree from Market Perform to Outperform.

  Equities Trading DOWN

Top 5 Consumer Service Companies To Buy Right Now: Micron Technology Inc.(MU)

Micron Technology, Inc., together with its subsidiaries, engages in the manufacture and marketing of semiconductor devices worldwide. Its products include dynamic random access memory (DRAM) products that provide data storage and retrieval, which include DDR2 and DDR3; and other specialty DRAM memory products, including DDR, SDRAM, DDR and DDR2 mobile low power DRAM, pseudo-static RAM, and reduced latency DRAM. The company also offers NAND flash memory products, which are electrically re-writeable and non-volatile semiconductor devices that retain content when power is turned off. In addition, it provides NOR flash memory products that are electrically re-writeable and non-volatile semiconductor memory devices; phase change memory products; and image sensor products. Micron Technology?s products are used in a range of electronic applications, including personal computers, workstations, network servers, mobile phones, flash memory cards, USB storage devices, digital still c ameras, MP3/4 players, and in automotive applications. It sells its products to original equipment manufacturers and retailers through internal sales force, independent sales representatives, and distributors, as well as through a Web-based customer direct sales channel. The company was founded in 1978 and is headquartered in Boise, Idaho.

Advisors' Opinion:

• [By Maureen Farrell]

  Earlier at the same conference, David Einhorn of Greenlight Capital Inc. said his firm has a long position in Micron Technologies(MU), according to people familiar with the matter.

• [By Andrew Tonner]

  It's been a wild ride for shares of Micron Technology (NASDAQ: MU  ) lately -- its shares doubled over the last year alone. Clearly the company's turnaround efforts have taken root, and the market's�handsomely rewarded those brave enough to buy into this recovery story. And while that's all well and good, what about the investor looking at Micron's shares today? Is there more upside to be had, or have we seen the end of Micron's rebound? In this edition of our Ask a Fool series, Fool contributor Andrew Tonner gives his take on the current state of affairs at Micron and if it's still worth a look today.

Top 5 Consumer Service Companies To Buy Right Now: JinkoSolar Holding Company Limited(JKS)

JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of solar power products in China and internationally. The company provides solar modules, silicon wafers and ingots, and solar cells, as well as processing services, including silicon wafer tolling services. It sells its products under the JinkoSolar brand name. The company?s customers include distributors, project developers, and system integrators. It trades its products under short-term contracts and by spot market sales. The company also produces accessory materials for solar power products, such as solar aluminum frame, solar junction box, aluminum materials windows, and other metal component parts. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People?s Republic of China.

Advisors' Opinion:

• [By Aaron Levitt]

  Like FSLR, CSIQ and JinkoSolar (JKS), ReneSola has moved beyond its original focus of creating just wafers. That means SOL stock investors are now betting on one of the more integrated solar stocks … and one that has grown to become a strong module shipper over the last few years. That includes outsourcing modules to nations like India, South Africa and Poland. SOL has done well in this regard and has been catching up to sizzling solar stocks like Yingli Green Energy (YGE).

• [By Wall Street Strategies]

  Naturally the news is a big positive for the industry, with Chinese solar names like Yingli (YGE), Trina (TSL), Canadian Solar (CSIQ) -- which is actually Chinese despite its name -- JinkoSolar (JKS), JA Solar (JASO), and LDK Solar (LDK) each up more than 10% at midday. The Guggenheim Solar ETF (TAN), which tracks several global solar companies, was up 8%, breaking to a new 52-week high.

• [By Aaron Levitt]

  And already, the price rise is beginning to take shape. According to its latest report, GTM shows that Chinese solar producers like JinkoSolar (JKS) have priced their modules at 80 to 85 cents per watt for new deliveries. That compares to just to 70 cents per watt at the end of 2013.

Top 5 Consumer Service Companies To Buy Right Now: TCF Financial Corporation(TCB)

TCF Financial Corporation operates as the bank holding company for TCF National Bank that provides various retail and commercial banking products and services in the United States and Canada. Its products and services include consumer, small business, and commercial deposits, as well as interest-bearing checking accounts, money market accounts, regular savings accounts, certificates of deposit, and retirement savings plans; and consumer real estate loans, commercial real estate loans, commercial business loans, and multi-purpose campus cards for colleges, as well as consumer loans for personal, family, or household purposes. The company also offers leasing and equipment finance products for various companies, inventory finance products, auto finance products, and treasury services. As of December 31, 2011, it had 434 retail banking branches, including 196 branches in Illinois, 110 in Minnesota, 53 in Michigan, 36 in Colorado, 26 in Wisconsin, 7 in Arizona, 5 in Indiana, an d 1 in South Dakota. The company was founded in 1923 and is based in Wayzata, Minnesota.

Advisors' Opinion:

• [By Zacks]

  Shares of TCF Financial Corporation (NYSE: TCB) have recorded a year-to-date return of 26.6%. Impressive organic growth, balance sheet repositioning and strong capital deployment activities of the company were primary factors behind the growth. However, we are not so optimistic about these positives translating into further price appreciation down the road as there will likely be significant pressure on its top line.

• [By Tim Melvin]

  I always find it very interesting to see what long-term investors are selling in a given quarter. Kahn Brothers lightened up on many financials that have shot up and now trade above book value. The firm sold out of Flushing Financial (FFIC), TCF Financial (TCB) and Dime Community Bank (DCOM). Khan apparently shares my views on the large-cap drug stocks, easing up on both Pfizer (PFE) and Bristol Meyers (BMY) over the summer. Khan Brothers also sold the last of the Travelers shares (TRV) it has owned since 2008 at more than twice the purchase price.

Best Internet Companies To Watch In Right Now

Related WUBA UPDATE: Pacific Crest Securities Reiterates On 58.com Following Strong Results/Guidance Market Wrap For May 22: Markets Barely Positive Related DANG Mid-Morning Market Update: Markets Gain; FactSet Posts Rise In Revenue Should Amazon Investors Be Worried About Alibaba? - Analyst Blog

Internet companies based in China were on a tear Thursday, with precious little news available to explain the trend.

Online marketplace provider 58.com Inc. (NYSE: WUBA) lead the trend with gains of 13.55 percent, trading at $52.11.

E-Commerce China Dangdang Inc. (NYSE: DANG), which offers Chinese language book,s gained 6.39 percent to $12.98.

Hot Rising Companies To Buy For 2015: CYNK Technology Corp (CYNK)

Cynk Technology Corp., formerly Introbuzz, Inc., is a development stage-company. The Company intends to develop a social network business. Social networks are Web based services that allow individuals to post a profile and link their profile to other friends and organizations.

The Company intends to develop a database of professional and other business persons, as well as other interested persons in providing and utilizing contacts. As of November 14, 2012, the Company had not generated any revenue.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  CYNK Technology (CYNK), the mysterious over-the-counter stock that at one point broke a $6 billion market cap, dropped roughly 80 percent in its first trades after a Securities and Exchange Commission halt. The SEC halted CYNK for two weeks following a massive rise in the stock's value -- it had been worth only a few cents per share in June, but it jumped above $21 on July 10. The Belize-based CYNK Technology supposedly operates a social networking site, but filings indicate it only has one employee and virtually no assets. Experts told CNBC the week of the SEC halt that they expected CYNK to fall precipitously after reopening, and its first day of trading is proving those predictions correct. When it was halted, the stock was worth just less than $14 per share, and is now below $3 a share after briefly hovering around $5 earlier Friday morning. An OTC Markets spokeswoman told Reuters that CYNK's shares were not trading on its platform, but were occurring over the phone. Earlier this week Reuters reported that OTC's CEO did not expect CYNK to trade on its platform at all after reopening, as no brokerages would file the required paperwork for the stock to trade on their exchanges. An SEC spokesman said that the organization cannot comment on the status of a company after a suspension period ends, citing an online explanation of the process. That document notes that broker-dealers may not solicit investors to trade the previously suspended OTC stock until they satisfy several regulatory requirements. The SEC warned, however, that "unsolicited" trading may occur after a reopening -- as CYNK is now seeing -- but "even though such trading is allowed, it can be very risky for investors without current and reliable information about the company."

Best Internet Companies To Watch In Right Now: Alibaba Group Holding Ltd (BABA)

Alibaba Group Holding Limited, incorporated on June 28, 1999, is an online and mobile commerce company. The Company operates its ecosystem as a platform for third parties. The Company operates Taobao Marketplace, China�� online shopping destination, Tmall, China�� third-party platform for brands and retailers and Juhuasuan, China�� group buying marketplace. In addition to its three China retail marketplaces, the Company operates Alibaba.com, China�� global online wholesale marketplace, 1688.com, its China wholesale marketplace, and AliExpress, its global consumer marketplace, as well as provides cloud computing services. As a platform, the Company provides the fundamental technology infrastructure and marketing reach to help businesses leverage the power of the Internet to establish an online presence and conduct commerce with consumers and businesses. Effective August 01, 2014, Alibaba Investment Ltd, a unit of Alibaba Group Holding Ltd, acquired a 10.193% interest n Singapore Post Ltd.

The buyers and sellers discover, select and transact with each other on the Company�� platform. Third-party service providers add value to its platform through service offerings that make it easier for buyers and sellers to do business. The third-party participants in its ecosystem include a payment services provider, logistics providers, retail operational partners, marketing affiliates, independent software vendors and various professional service providers. The Company has developed policies and procedures that maintain the health and sustainability of its marketplaces, including consumer protection programs, marketplace rules, qualification standards for merchants and buyer and seller rating systems. As its ecosystem expands, new jobs are created.

Taobao Affiliate Network is powered by Alimama, its online marketing technology platform. Through this platform, sellers place marketing displays on its marketing affiliates��websites and mobile apps, and sellers pay a performance-b! ased marketing fee primarily based on cost-per-click (CPC), and cost-per-sale (CPS), models. Through China Smart Logistics, the Company provides real-time information to its logistics partners, including key operating metrics, such as distribution center utilization rates, route planning data and order volume forecasts. Independent software vendors (ISVs) provide software tools, as well as systems integration services to sellers.

Tmall is an online platform featuring brands and retailers with each seller having an identifiable online storefront. Users may access Tmall anytime, anywhere through the Tmall Website and the mobile apps and mobile-optimized websites provided by Taobao Marketplace and Tmall. The physical product categories on Tmall include apparel and accessories, electronics and appliances, home furnishings, home appliances, maternity and baby products. Juhuasuan is an online group buying marketplace in China. Juhuasuan offers quality products at discounted prices by aggregating demand from numerous consumers. Juhuasuan mainly does this through flash sales, which make products available at discounted prices for a limited period of time. Juhuasuan offers group buying channels featuring branded and private label products, products made to custom specifications and local services.

AliExpress is a consumer marketplace enables consumers from around the world to buy directly from wholesalers and manufacturers in China. On AliExpress, consumers have access to a variety of products. In addition to the global English-language site, AliExpress operates two local language sites in Russia and Brazil. The product categories on AliExpress.com include apparel and accessories, phones and communications products, beauty and health, computer networking, jewelry and watches. Alibaba.com is an online commerce platform. Sellers on Alibaba.com may pay for an annual Gold Supplier membership to host a premium storefront with product listings on the marketplace.

The Company��! marketin! g technology platform, Alimama, offers sellers on its marketplaces marketing services for both personal computer and mobile devices, which include P4P marketing service and display marketing. Alimama also offers its sellers these marketing services through third parties through the Taobao Affiliate Network. The Taobao Ad Network and Exchange (TANX) automates the buying and selling of billions of advertising impressions on a daily basis by third parties. The Company also offer a data management platform (DMP), connected to TANX. Its DMP allows participants on TANX to evaluate and select online advertising inventory using both behavioral data they provide, as well as data from browsing behavior and shopping history. Its Cloud Computing supports its commerce ecosystem by providing a distributed computing infrastructure to handle the large volume of traffic and data generated on its online marketplaces. Its cloud computing platform offers service offerings, including elastic computing, database services and storage and large scale computing services.

The company offer search functions on all of its Web pages, mobile apps and many of its marketing affiliates��websites and apps to make it easy for buyers to find products and services within its marketplaces. The Company offers Aliwangwang, a personal computer-based instant messenger that supports text, audio and video communication. The Company developed Aliwangwang to facilitate open communication between buyers and sellers on Taobao Marketplace and Tmall. Buyers and sellers use it as a tool for a range of tasks, including negotiation of prices, customer services and delivery notification, in addition to the basic messaging functions. It offer Qianniu , an integrated platform for communication and productivity tools which allows sellers on Taobao Marketplace and Tmall to manage their operations more efficiently.

Alipay, the Company�� related company, provides payment and escrow services for transactions on Taobao Marketplace, Tm! all, 1688! .com and certain of its other sites, as well as to third parties in China. The Company�� small and medium enterprise (SME) loan business provides micro loans to sellers on its wholesale and retail marketplaces through lending vehicles licensed by the local government.

The company competes with Tencent and Baidu.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  Many analysts expect Alibaba Group Holding Ltd. (NYSE: BABA) to raise more than $20 billion. That would surpass the $19.65 billion Visa Inc. (NYSE: V) raised in 2008 and make Alibaba the largest U.S. IPO to date.

• [By Luke Jacobi]

  Alibaba Group Holding Ltd (NYSE: BABA) made its debut as a publicly traded company in the largest IPO of all time.

  TD Ameritrade reported that it had more orders for shares of Alibaba prior to the stock’s open than orders for Facebook before it began trading for the first time.

• [By MONEYMORNING.COM]

  And with Alibaba Group Holding Ltd. (NYSE: BABA) - China's No. 1 e-commerce player - scheduled to go public soon, investors are suddenly seeing the potential of the country's online marketplace.

• [By WWW.DAILYFINANCE.COM]

  ChinaFotoPress/Getty ImagesEmployees cheer at Alibaba headquartes in China as its stock debuts in New York. At $231 billion, Alibaba Group (BABA) closed Friday with more than twice the market cap of Facebook (FB), three times that of eBay (EBAY), and about 50 percent more than Amazon.com (AMZN). For founder Jack Ma, the run-up means he's now worth more than $20 billion, according to Forbes' estimates. Yahoo (YHOO), meanwhile, is now sitting on a stake that was worth more than $49 billion the day of the initial public offiering -- about $10 billion more than its current market cap.

Best Internet Companies To Watch In Right Now: Symantec Corporation(SYMC)

Symantec Corporation provides security, storage, and systems management solutions internationally. The company?s Consumer segment delivers Internet security, PC tune-up, and online backup solutions and services to individual users and home offices. Its Security and Compliance segment provides solutions for endpoint security and management, compliance, messaging management, data loss prevention, encryption, and authentication services to large, medium, and small-sized businesses, as well as offers solutions through its software-as-a-service (SaaS) security offerings. This segment?s products enable customers to secure, provision, and remotely manage their laptops, PCs, mobile devices, and servers. The company?s Storage and Server Management segment provides storage and server management, backup, archiving, and data protection solutions across heterogeneous storage and server platforms, as well as solutions delivered through its SaaS offerings to large, medium, and small-s ized businesses. Symantec?s Services segment offers implementation services and solutions, including consulting, business critical services, education, and managed security services. The company also provides various enterprise support offerings, such as annual maintenance support contracts, including content, upgrades, and technical support. It sells its products through its eCommerce platform, as well as through distributors, direct marketers, Internet-based resellers, system builders, ISPs, and retail locations worldwide. Symantec markets and sells its products through distributors, retailers, direct marketers, Internet-based resellers, original equipment manufacturers, system builders, and Internet service providers; and its e-commerce channels, as well as direct sales force, value-added and large account resellers, and system integrators. The company was founded in 1982 and is headquartered in Mountain View, California.

Advisors' Opinion:

• [By Shauna O'Brien]

  On Thursday, Morgan Stanley reported that it has downgraded security and storage management company Symantec Corporation (SYMC).

  Morgan Stanley has cut its rating on SYMC to an “Equal Weight.” Analysts believe that the company lacks near term catalysts.

  Symantec shares were down 55 cents, or 2.18%, during pre-market trading Thursday. The stock is up 34% YTD.

Best Internet Companies To Watch In Right Now: Propell Technologies Group Inc (PROP)

Propell Technologies Group, Inc., incorporated on February 04, 2008, offers enhanced oil recovery technology and services. These services are offered through its wholly owned subsidiary Novas Energy USA, Inc., through commercial application of a Plasma-Pulse Technology.

The Company�� technology is designed to be suitable for oil wells as deep as 12,000 feet. Novas�� Plasma-Pulse Treatment is an Enhanced Oil Recovery (EOR) technology and process. The treatment uses no chemicals.

Advisors' Opinion:

• [By John Udovich]

  Although oil prices ended the year at multi year lows, now would be the time to take a closer look at�small cap gas compression or enhanced oil recovery (EOR) stocks like�Usa Compression Partners LP (NYSE: USAC), CSI Compressco LP (NASDAQ: CCLP) and Propell Technologies Group Inc (OTCBB: PROP) before oil and gas prices inevitably rise again. To begin with, natural gas compression services are used to transport natural gas and specifically to get�natural gas from low-pressure wells into gathering systems, storage and processing facilities�as well as to maintain production as reservoir pressure declines. Compression services�are also used to extract gas from�unconventional natural gas sources like shale plays. Meanwhile,�so-called enhanced oil recovery or EOR is just a generic term for the techniques used for increasing the amount of crude oil that can be extracted from an oil field with potential methods including steam flood and water flood injection�or hydraulic fracturing�(so-called fracking). Naturally, demand for compression services and EOR technologies would be impacted by oil and gas commodity prices.

Best Internet Companies To Watch In Right Now: Yahoo! Inc.(YHOO)

Yahoo! Inc., together with its subsidiaries, operates as a digital media company that delivers personalized digital content and experiences through various devices worldwide. It offers online properties and services to users; and a range of marketing services to businesses. The company?s communications and communities offerings include Yahoo! Mail, Yahoo! Messenger, Yahoo! Groups, Yahoo! Answers, Flickr, and Connected TV, which provide a range of communication and social services to users and small businesses enabling users to organize into groups and share knowledge, common interests, and photos. Its search products comprise Yahoo! Search and Yahoo! Local, available free to users to navigate the Internet and discover content. The company?s marketplaces offerings and services include Yahoo! Shopping, Yahoo! Travel, Yahoo! Real Estate, Yahoo! Autos, and Yahoo! Small Business, which allow users to research specific topics, products, services, or areas of interest by review ing and exchanging information, obtaining contact details, or considering offers from providers of goods, services, or parties with similar interests. Its media offerings comprise Yahoo! Homepage, Yahoo! News, Yahoo! Sports, Yahoo! Finance, My Yahoo!, Yahoo! Toolbar, Yahoo! Entertainment & Lifestyles, Yahoo! Contributor Network, and Yahoo! Pulse, which are designed to engage users with online content and services on the Web. The company also offers marketing services, such as display and search advertising, listing-based services, and commerce-based transactions to advertisers. In addition, it provides software and platform offerings for third-party developers, advertisers, and publishers, such as Yahoo! Developer Network, Yahoo! Open Strategy, Yahoo! Application Platform, Yahoo! Updates, Yahoo! Query Language, and Yahoo! Search BOSS. The company has strategic alliances with Nokia and ABC News, Inc. Yahoo! Inc. was founded in 1994 and is headquartered in Sunnyvale, Californi a.

Advisors' Opinion:

• [By Tom Jacobs]

  The following table examines year-over-year quarterly DSOs, and then the more important sequential change in LTM DSOs at four companies competing with each other fiercely in many areas: Google (NASDAQ: GOOG  ) , Apple (NASDAQ: AAPL  ) , Microsoft (NASDAQ: MSFT  ) , and Yahoo! (NASDAQ: YHOO  ) . There's clearly a big fifth in�Facebook,�but we lack enough data for anything meaningful on DSOs so far.�

• [By WALLSTCHEATSHEET]

  Yahoo is an Internet bellwether that provides a multitude of services to consumers and companies worldwide. A recent earnings announcements had investors expecting a little more from the company. The stock has been moving higher in recent quarters and is now trading near highs for the year. Over the last four quarters, earnings and revenues have been mixed which have produced conflicting feelings among investors about earnings announcements. Relative to its peers and sector, Yahoo has been a year-to-date performance leader. Look for Yahoo to OUTPERFORM.

• [By arti7]

  This particular case is one part of the nationwide litigation that is being overseen by Judge Koh and consolidates 19 other related lawsuits. Apple is not the only company facing lawsuits such as this one. Many other big tech companies like Yahoo! Inc (YHOO), Google Inc (GOOG), Facebook Inc (FB) and Microsoft Corporation (MSFT) have also been caught in the fray regarding privacy and location data.

• [By Garrett Cook]

  Yahoo! (NASDAQ: YHOO) was down, falling 4.90 percent to $33.87 after the company reported weaker-than-expected second-quarter results. The company announced it will reduce the number of shares being offered in the Alibaba IPO from 208 million shares to 140 million shares.

Best Internet Companies To Watch In Right Now: Amazon.com Inc.(AMZN)

Amazon.com, Inc. operates as an online retailer in North America and internationally. It operates retail Web sites, including amazon.com and amazon.ca. The company serves consumers through its retail Web sites and focuses on selection, price, and convenience. It also offers programs that enable sellers to sell their products on its Web sites, and their own branded Web sites. In addition, the company serves developer customers through Amazon Web Services, which provides access to technology infrastructure that developers can use to enable virtually various type of business. Further, it manufactures and sells the Kindle e-reader. Additionally, the company provides fulfillment; miscellaneous marketing and promotional agreements, such as online advertising; and co-branded credit cards. Amazon.com, Inc. was founded in 1994 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By Rick Munarriz]

  2. Amazon wants to direct
  The return this past weekend of Arrested Development may have been a big deal for Amazon.com's (NASDAQ: AMZN  ) streaming rival, but the leading online retailer isn't asleep at the wheel when it comes to original programming.

• [By Chris Hill]

  The S&P and the Dow hit new all-time highs on Wednesday, in the wake of news that the Federal Reserve is thinking about ending its quantitative-easing policy. What would the end of easy money mean for investors? Which stocks stand to benefit? In this installment of Investor Beat, our analysts explain why tech giants such as Apple (NASDAQ: AAPL  ) , Amazon.com (NASDAQ: AMZN  ) , and Google (NASDAQ: GOOG  ) could emerge as big winners if the Fed changes course.

Best Internet Companies To Watch In Right Now: IAC/InterActiveCorp (IACI)

IAC/InterActiveCorp engages in the Internet business in the United States and internationally. The company�s Search segment develops, markets, and distributes various downloadable toolbars; provides search, reference, and content services through its destination search and other Websites, including Ask.com and Dictionary.com; and aggregates and integrates local advertising and content for distribution to publishers on Web and mobile platforms, as well as markets and distributes mobile applications through which it provides search and additional services. Its Match segment offers subscription-based and advertiser-supported online personals services through its Websites comprising Match.com, Chemistry.com, OurTime.com, BlackPeopleMeet.com, and OkCupid.com, as well as through mobile applications and Meetic-branded Websites. The company�s ServiceMagic segment offers Market Match service that matches consumers with service professionals; Exact Match service, which enables con sumers to review service professional profiles and select the service professional that meets their specific needs; and 1800Contractor.com, an online directory of service professionals. This segment also offers Website design and hosting services. Its Media and Other segment operates CollegeHumor.com, an online entertainment Website that targets young males; Vimeo, a Website on which users can upload, share, and view video; and Pronto.com, a comparison search engine. This segment also engages in the creation of video content for various distribution platforms; and operates as an Internet retailer of footwear and related apparel and accessories, as well as focuses on multimedia business. The company was formerly known as InterActiveCorp and changed its name to IAC/InterActiveCorp in July 2004. IAC/InterActiveCorp was founded in 1986 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Chris Isidore]

  Newsweek, the news magazine whose print version was abandoned late last year, was sold in August by IAC (IACI) to another all-digital news company, IBT Media.

Top Life Sciences Companies To Buy For 2015

Top Life Sciences Companies To Buy For 2015: Redcliffe Resources Ltd (RCF)

Redcliffe Resources Limited, formerly Pacrim Energy Limited, is engaged in gold exploration. The Company own 100% interest in Redcliffe Gold Project. The Redcliffe Gold Project lies northeast of the mining town of Leonora, which is 230 kilometer north of Kalgoorlie in Western Australia. The Project covers approximately 45 kilometers of strike length of the Mertondale Shear Zone (MSZ) along with parallel and associated structures. The Golden Terrace South (GTS) deposit lies within a granted mining lease in the southern portion of the Redcliffe Gold Project. The 727 Prospect is located less than five kilometer south east of Golden Terrace. The Kelly Prospect lies along the Mertondale Shear Zone some three to four kilometer north of Golden Terrace South. Advisors' Opinion:

• [By Tom Stoukas]

  Teleperformance SA (RCF) climbed 2.9 percent to 35.10 euros. Societe Generale SA raised its recommendation on the French operator of call centers to buy from hold. The brokerage said the shares recent decline provides a buying opportunity. The stock has fallen 14 percent since its high on July 18.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-life-sciences-companies-to-buy-for-2015-3.html

Top 5 Biotech Companies To Invest In Right Now

So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

Rexahn Pharmaceuticals. After announcing two years ago that it would stop working on depression drug Serdaxin, Rexahn Pharmaceuticals has since shifted its focus to the discovery and development of new drugs to treat cancer.

Top 5 Oil Service Stocks To Invest In Right Now: Horizon Pharma Inc (HZNP)

Horizon Pharma, Inc. (Horizon), incorporated on March 23, 2010, is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company�� other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company�� distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation. On April 1, 2010, Horizon effected a recapitalization and acquisition pursuant to which Horizon Pharma, Inc. became a holding company, that operates through its wholly owned subsidiaries, Horizon Pharma USA, Inc. (formerly Horizon Therapeutics, Inc.) and Horizon Pharma AG (formerly Nitec Pharma AG (Nitec)).

DUEXIS

DUEXIS is a combination of 800 milligram ibuprofen and 26.6 milligram famotidine in a single pill and is indicated for the relief of signs and symptoms of rheumatoid arthritis (RA), and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal (GI), ulcers in patients who are taking ibuprofen for those indications. The Company has completed two Phase III clinical trials in a total of over 1,500 patients with mild to moderate pain or arthritis that demonstrated a significant reduction in the incidence of non-steroidal anti-inflammatory drugs (NSAID)-induced upper GI ulcers when treated with DUEXIS versus ibuprofen alone.

LODOTRA

LODOTRA is a programmed release formulation of low-dose prednisone, a well-established drug use! d to inhibit the production of various pro-inflammatory cytokines, which are proteins associated with joint inflammation in RA. LODOTRA has received regulatory approval in Europe for the treatment of moderate to severe, active RA in adults when accompanied by morning stiffness. As of December 31, 2010, the Company had completed two pivotal Phase III clinical trials of LODOTRA in a total of over 600 patients with RA. The first pivotal Phase III trial supported the approval of LODOTRA in Europe in March 2009, where it is approved for marketing in 14 European countries. LODOTRA achieved significant results and met the primary endpoint in each of the two pivotal Phase III clinical trials. Its LODOTRA product was developed and is owned by Horizon Pharma AG. As of December 31, 2010, the Company markets LODOTRA in Europe through three separate agreements. Pursuant to two separate agreements, it granted Merck Serono GmbH and Merck GesmbH, an affiliate of Merck Serono, the rights to distribute and market LODOTRA in each of Germany and Austria, respectively, and pursuant to the third agreement, it granted Mundipharma rights to distribute and market LODOTRA in the rest of Europe. The Company also has a manufacturing and supply agreement with Jagotec AG under which Jagotec or its affiliates manufacture and supply LODOTRA to the Company as bulk tablets.

The Company competes with Pfizer Inc., Pozen Inc., Abbott Laboratories and Amgen Inc.

Advisors' Opinion:

• [By Lisa Levin]

  Horizon Pharma (NASDAQ: HZNP) shares reached a new 52-week high of $17.12 after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.

• [By Lisa Levin]

  Horizon Pharma (NASDAQ: HZNP) shares gained 24.15% to $18.23 after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.

• [By Jake L'Ecuyer]

  Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.

  Top Headline
  The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million.

• [By Monica Gerson]

  Horizon Pharma (NASDAQ: HZNP) shares dropped 5.29% to $12.90 in pre-market trading after the company reported Q4 results. Horizon Pharma posted a quarterly loss of $0.04 per share on revenue of $30.10 million. However, analysts were expecting a loss of $0.08 per share on revenue of $32.18 million.

Top 5 Biotech Companies To Invest In Right Now: Incyte Corporation(INCY)

Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Its product pipe line includes INCB18424, which is in Phase III clinical trial for myelofibrosis; Phase III trial for polycythemia vera; Phase III trial for essential thrombocythemia; Phase I/II trial to treat solid tumors/other hematologic malignancies; and Phase IIb trail for the treatment of psoriasis. The company?s portfolio also includes INCB28050, a Phase IIb clinical trial product for rheumatoid arthritis; INCB28060, a Phase I/II product for solid tumors; INCB7839, a Phase II product for breast cancer; and INCB24360, a Phase I/II product for solid tumors. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded in 1991 and is headquartered in Wilmington, Delaware.

Advisors' Opinion:

• [By Ben Levisohn]

  Vertex has dropped 6.1% to $66.97 today at 2:24 p.m. but it’s fall doesn’t seem to be having an impact on other biotech companies. Incyte (INCY) gained 2% to $39.77, Acorda Therapeutics (ACOR) has gained 0.7% to $30.83 and Regeneron Pharmaceuticals (REGN) has dropped 0.6% to $285.96.

• [By Ben Levisohn]

  Sure Intercept Pharmaceuticals (ICPT) might feel like the only biotech stock that matters today, but there are others. For instance, Incyte (INCY) and� BioMarin (BMRN) are on the move after Barclays changed its ratings on the pair.

• [By Ben Levisohn]

  Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.

• [By Maxx Chatsko]

  The best part about being a buy-and-hold investor is that when volatility strikes and analysts and pundits are panicking, you can calmly go about your business and steal great companies at bargain prices. One of the stocks on my top watchlist is Incyte (NASDAQ: INCY  ) , which is a growing biotech company focused on developing oncology and anti-inflammatory drugs. The company's shares have recently fallen below $20 for the first time since early February, which I think warrants a deeper look. In the following video, I'll break down the pros and cons of adding Incyte to your portfolio, although I think the company has a lot of potential in its pipeline.

Top 5 Biotech Companies To Invest In Right Now: Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals Inc., incorporated on July 13, 2005, is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease. The Company�� initial development strategy targets indications for emricasan with high unmet clinical need in orphan patient populations, such as patients with acute-on-chronic liver failure (ACLF), chronic liver failure (CLF), and patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection (HCV-POLT).

The Company has completed two placebo-controlled Phase II trials in patients with liver disease showing reductions in ALT levels that occur rapidly, within as little as one day after initiation of therapy, and are maintained throughout the treatment period. In the Company�� 204-patient Phase 2b trial, it also measured cCK18, an important biomarker of apoptosis and disease severity. Emricasan has been generally well-tolerated in all of the clinical studies. As of July 23, 2013, the Company had not generated any revenue.

Advisors' Opinion:

• [By John Udovich]

  While Intercept Pharmaceuticals Inc (NASDAQ: ICPT) surged earlier this year and Achillion Pharmaceuticals, Inc (NASDAQ: ACHN) has surged this week after Merck & Co. Inc (NYSE: MRK) agreed to purchase hepatitis stock�Idenix Pharmaceuticals Inc (NASDAQ: IDIX) at a 239% premium, it seems the herd has realized that small cap Conatus Pharmaceuticals Inc (NASDAQ: CNAT) is also a liver disease stock as shares suddenly surged 56.69% on no apparent company news. But just what is�Conatus Pharmaceuticals and is it worth taking a chance on?

• [By John Udovich]

  Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).

Top 5 Biotech Companies To Invest In Right Now: Mast Therapeutics Inc (MSTX)

Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., incorporated in December 1995, is a development-stage company biopharmaceutical company focused on developing product candidates. The Company's product candidate is ANX-188, a rheologic, antithrombotic and cytoprotective agent that improves microvascular blood flow and has application in treating a range of diseases and conditions, such as complications arising from sickle cell disease. As of December 31, 2011, the Company also is developing ANX-514, a detergent-free formulation of the chemotherapy drug docetaxel. The Company offers ANX-188 (purified poloxamer 188), ANX-514 (docetaxel for injectable emulsion) and Exelbine (vinorelbine injectable emulsion). In April 2011, the Company acquired SynthRx, Inc. In February 2014, Mast Therapeutics Inc completed its acquisition of Aires Pharmaceuticals, Inc. Aires became a wholly-owned subsidiary of Mast Therapeutics.

ANX-188 (purified poloxamer 188)

ANX-188 is an aqueous solution of a purified form of poloxamer 188. Poloxamer 188 (P1880, is a nonionic, block copolymer that has been found to improve microvascular blood flow by reducing viscosity, particularly under low shear conditions, and by reducing adhesive frictional forces. The Company�� purified form of P188 (purified P188), which is the active ingredient in ANX-188, was designed to eliminate certain low molecular weight substances present in P188 (non-purified), which is primarily responsible for the moderate to moderately severe elevations in serum creatinine levels (acute renal dysfunction) observed in prior clinical studies of P188 (non-purified). Purified P188 has been evaluated in multiple clinical studies by a prior sponsor, including a 255-patient, phase III study.

ANX-514 (docetaxel for injectable emulsion)

ANX-514 is a detergent-free emulsion formulation of docetaxel, an intravenously-injected chemotherapy drug commonly used to treat solid tumors. Taxotere, a branded form! ulation of docetaxel, is approved to treat breast, non-small cell lung, prostate, gastric, and head and neck cancers. ANX-514 was designed to have clinically comparable release of docetaxel relative to Taxotere while eliminating the presence of polysorbate 80 and ethanol, both of which are used to solubilize docetaxel in the Taxotere formulation. The ANX-514 formulation solubilizes docetaxel using oil droplets consists of a combination of non-toxic excipients. Docetaxel is contained within these oil droplets and can be administered intravenously without using detergents as pharmaceutical vehicles. Once in central circulation, the emulsion is metabolized rapidly, leaving chemically-identical active ingredient to exert its cytotoxic effect. ANX-514 may reduce the incidence and severity of hypersensitivity reactions and delay the onset of fluid retention.

Exelbine (vinorelbine injectable emulsion)

Exelbine is an emulsion formulation of the chemotherapy drug vinorelbine. Navelbine, a branded formulation of vinorelbine, is approved in the United States to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, and approved in the European Union to treat non-small cell lung cancer and advanced or metastatic breast cancer.

In August 2011, the Company received a complete response letter from the Food and Drug Administration (FDA) stating that it could not approve the Exelbine Non Disclosure Agreement (NDA) in its present form and that the bioequivalence study would need to be repeated because the authenticity of the drug products used in the bioequivalence trial could not be verified in accordance with FDA standards. However, the Company elected to discontinue independent development of Exelbine and as of December 31, 2011, the Company was seeking a partner or outside investor for the program to complete the necessary bioequivalence study.

The Company competes with GlaxoSmithKline, Provenge and Pfizer.

Advisors' Opinion:

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

• [By Roberto Pedone]

   

  Mast Therapeutics (MSTX), a biopharmaceutical company, focuses on developing therapies for serious or life-threatening diseases. This stock closed up 2.1% 65 cents per share in Thursday's trading session.

   

  Thursday's Range: $0.63-$0.67
  
  52-Week Range: $0.40-$1.10
  
  Thursday's Volume: 1.11 million
  
  Three-Month Average Volume: 1.88 million

   

  From a technical perspective, MSTX spiked modestly higher here right above its 50-day moving average of 61 cents per share with decent upside volume. This stock has been trending sideways and consolidating for the last month, with shares moving between 60 cents on the downside and 72 cents on the upside. Shares of MSTX are now starting to push higher and into range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if MSTX manages to clear some near-term overhead resistance levels at 68 to 72 cents per share with high volume.

   

  Traders should now look for long-biased trades in MSTX as long as it's trending above some key near-term support at 60 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.88 million shares. If that breakout materializes soon, then MSTX will set up to re-test or possibly take out its next major overhead resistance levels at 80 to 85 cents per share, or even 93 cents per share.

   

• [By James E. Brumley]

  A little over a month ago, owning Mast Therapeutics, Inc. (NYSE: MSTX) was nothing but pure misery. Shares plunged from $0.63 to $0.43 in one day, when details of a dilutive public offering were unveiled. As is so often the case though, the market may have overshot with the selling effort that KO's MSTX. Though putting more shares 'out there' mathematically meant existing shareholders would have to share more of the company's upside with newcomers, what's slowly coming to light is that the inflow of new cash is still more advantageous to those prior shareholders; the company would progress little without it.

• [By Lauren Pollock]

  Mast Therapeutics Inc.(MSTX) said the U.S. Food and Drug Administration gave orphan-drug designation to its MST-188 drug for the treatment of acute limb ischemia, providing a boost for the biopharmaceutical firm. Shares surged.

Morning Movers: Lorillard Leaps on Reynolds American Merger Speculation; The Gap Falls on Weak Sales

Stocks look set to open higher a day after concerns surrounding a Portuguese bank caused stocks to fall.

AA

S&P 500 futures have risen 0.2%, while Dow Jones Industrial Average futures have gained 0.2%. Nasdaq Composite futures have advanced 0.3%.

Lorillard (LO) has jumped 5.5% to $66.55 after reports that the tobacco company was set to merge–finally–with Reynolds American (RAI). Reynolds American has gained 2.9% to $62.26.

Top Telecom Companies To Watch In Right Now

The Gap (GPS) has fallen 1.3% to $40.44 after it said sales at stores open for at least 12 months had dropped 2% in June.

Fastenal (FAST) has fallen 3% to $46.71 after the industrial company reported earnings that met analyst forecasts but light revenue.

Marathon Petroleum (MPC) has risen 1.1% to $78.29 after getting upgraded to Buy from Neutral at Citigroup.

Hot Trucking Companies To Own For 2015

Hot Trucking Companies To Own For 2015: Approach Resources Inc.(AREX)

Approach Resources Inc., an independent energy company, engages in the acquisition, exploration, development, and production of oil and gas properties in the United States. The company primarily holds interests in properties located in the Permian Basin in West Texas, as well as in the East Texas Basin. As of December 31, 2011, it had estimated proved reserves of approximately 77.0 million barrels of oil equivalent, and owned working interests in 638 producing oil and gas wells. Approach Resources Inc. was incorporated in 2002 and is headquartered in Fort Worth, Texas.

Advisors' Opinion:

• [By Travis Hoium]

  What: Shares of Approach Resources (NASDAQ: AREX  ) dropped 10% today after the company released earnings.

  So what: Sales rose 33.8% from a year ago, to $44.2 million, and the company swung to a profit of $495,000, or $0.01 per share. After adjusting for one-time items, the company made a profit of $0.07 per share, in line with estimates. 

• [By Ben Levisohn]

  Not all stocks are created equal, however, and the analysts expect some stocks to handily outperform others, and their top picks “are poised to deliver long-term, capital-efficient growth…while trading at attractive valuations that currently provide 20%+ upside to our price targets.” Their winners? Oasis Petroleum (OAS), Approach Resources (AREX), Bonanza Creek Energy (BCEI) and Gulfport Energy (GPOR), all of which are rated Buy with Oasis also added to Goldman’s conviction list. Investors, however, should avoid  WPX Energy (WPX), which the analysts rate a Sell. They explain why:

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-trucking-companies-to-own-for-2015-4.html

Pershing to Launch Retirement Plan Network

Pershing says it will roll out a retirement plan program later this year to help advisors, broker-dealers and RIAs grow their business. These plans, which advisors would custody at Pershing, will be integrated with third-party administrators and recordkeepers on the new platform.

“The Retirement Plan Network will allow our clients to target these plans, and, at the same time, to opt to serve small- and medium-size business owners by managing their personal assets, for instance,” said Robert Cirrotti, director of retirement solutions, in an interview Thursday during the group’s annual Insite conference in Hollywood,  Fla.

For advisors, this new Pershing service gives them increased efficiency, Cirrrotti says, with the ability to work across different recordkeepers; for RIAs, as they manage services like asset-allocation models, it means they can do such work across various retirement plans and recordkeepers; and for broker-dealers, it brings greater transparency and oversight via a single platform that works with multiple third-party administrators.

“This should make Pershing a hub for retirement-centric advisors,” Cirrotti explained, “as we help them move through the lifecycle from selling the retirement plan work to servicing and managing it.”

In other news, Pershing said Thursday that one of its affiliates, Albridge, is in the process of introducing a new Albridge Wealth Reporting platform with enhanced functionality so advisors can better leverage client portfolio data and provide investors with accurate and insightful analysis.

“The new Albridge Wealth Reporting platform goes far beyond anything we have brought to market before,” explained Peter Antonucci, managing director at Pershing, in a statement. “We were focused on reimagining a framework for data management, reporting, workflow and accessibility. The result is a solution that is robust, flexible and more intuitive.” 

'Positive' Directions

Pershing’s tech news is one of several themes being highlighted at its annual conference.

The economy is “heading in right direction,” said Pershing CEO Ron DeCicco, adding that the firm is optimistic about the markets the advisory business tied to them.

“The U.S. is in the mid-cycle of an eight-year expansion, with growth likely to accelerate for the next three years,” DeCicco said on Wednesday, before an audience of about 2,000 advisors and others attending the group’s annual Insite conference. “Companies are cautiously hiring, and we are seeing positive trends on the Pershing platform.”

Client assets, as of April 30, stand at almost $1.5 trillion, vs. $943 billion in 2009 and $1.4 trillion in 2013.

As for asset allocation, clients hold about 31% of their portfolios in equities. By product, mutual funds (excluding ETFs) represent 34% of portfolios, but ETFs are catching up; they account for nearly 6% of assets today.

“The strongest flows are into global and international funds, indicating demand for … more diversification,” said DeCicco.

Those investors working with an advisor “create more assets than those who are not,” he notes, pointing to data that shows these households had grown their assets 173% over 15 years.

Clients also are favoring products that they can invest in with no fees. The level of assets held in no-fee products (on Pershing’s FundVest platform) stood at $406 billion 2013, up from $338 billion in 2012. 

---

Check out 10 Steps to Becoming a Multigenerational Advisor: Pershing on ThinkAdvisor.

Top 10 Dow Dividend Stocks To Buy Right Now

Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its upcoming dividend payout. For more information, check out Everything Investors Need to Know About Ex-Dividend Dates.

Below are six stocks going ex-dividend on Tuesday, July 8.

1. Verizon

Verizon (VZ) offers a dividend yield of 4.26% based on Thursday�� closing price of $49.71 and the company�� quarterly dividend payout of 53 cents. The stock is up 1% year-to-date. Dividend.com currently rates VZ as “Recommended” with a DARS��rating of 3.5 stars out of 5 stars.

10 Best High Dividend Stocks To Watch For 2015: Pitney Bowes Inc(PBI)

Pitney Bowes Inc. provides mail processing equipment and integrated mail solutions worldwide. It offers a suite of equipment, supplies, software, services, and solutions for managing and integrating physical and digital communication channels. The company?s Small & Medium Business Solutions group engages in the sale, rental, and financing of mail finishing, mail creation, and shipping equipment and software; provision of supply, support, and other professional services; and provision of payment solutions. Its Enterprise Business Solutions group sells, supports, and offers other professional services for high-speed production mail systems, and sorting and production print equipment; and sells and provides support services for non-equipment-based mailing, customer relationship and communication, and location intelligence software. This group also offers facilities management services; secure mail services; reprographic document management services; and litigation support and eDiscovery services, as well as provides presort mail services and cross-border mail services; and direct marketing services. Pitney Bowes Inc. markets its products and services through its sales force, direct mailings, outbound telemarketing, and independent distributors and dealers to various business, governmental, institutional, and other organizations. The company, formerly known as Pitney Bowes Postage Meter Company, was founded in 1920 and headquartered in Stamford, Connecticut.

Advisors' Opinion:

• [By Dan Caplinger]

  Pitney Bowes (NYSE: PBI  ) also became a victim of a dividend cut as it chose to reduce its payout by half in order to help it conserve cash as its financial results have deteriorated. With the very difficult task of repositioning itself from the largely obsolete postage business to become a more full-service enterprise communications company, Pitney Bowes will need as much spare cash as possible to reinvest in its new business opportunities.

• [By Ben Levisohn]

  Combine Yellen’s dovishness–if it really is dovishness–with idiosyncratic company news, and some stocks were guaranteed to take off. Iron Mountain (IRM), for instance, gained 12% this week after the IRS said it had ended a working group considering REIT conversions and would now turn to its application. Pitney Bowes (PBI), meanwhile, rose 11% this week after activist investor Jana Partners revealed it had accumulated a large stake in the stock. Macy’s (M) advanced 11% after reporting much better earnings than forecast by analysts. Marathon Petroleum (MPC) finished the week up 10% as the difference between the price of oil here in the U.S. and the price abroad widened. Rounding out the top-five: J.C. Penney (JCP). The beaten-down retailer rose 9.7% this week, getting a boost from positive analyst comments and hedge-fund purchases.

• [By Sean Williams]

  Finally, mail logistics software solutions company Pitney Bowes (NYSE: PBI  ) jumped 3.7% after announcing the appointment of Roger Pilc as executive vice president and chief innovation officer. Pilc will be a welcome face for Pitney Bowes, which has struggled under the weight of lower physical mail volume and increasing competition. Pilc, who comes over from CA Technologies (NASDAQ: CA  ) , helped head CA's cloud development segment, which may transform CA back into a high-growth company over the next few years as it invests heavily in R&D. Pitney Bowes certainly needs as many ideas as it can get to stem a precipitous downtrend in sales, so we'll have to see how this move works out for all parties involved.

• [By Double Dividend Stocks]

  So, should you abandon steady dividend streams and try to time the market with non-paying stocks? Take a look at the S&P 2013 non- dividend paying winners as of 9/30/13. 4 stocks out of this top 10 group aren't profitable firms, the highest yielding stock, Pitney Bowes, (PBI), has a Price/Book of over 185 and a mountain of debt, and the 2nd best performer, Netflix, (NFLX), has a P/E over 400! PBI also had a Short Ratio of over 15 as of 9/30/13.

Top 10 Dow Dividend Stocks To Buy Right Now: Flexpoint Sensor Systems Inc (FLXT)

Flexpoint Sensor Systems, Inc.(Flexpoint), incorporated on June 11, 1992, is a development stage company. The Company is principally engaged in designing, engineering and manufacturing bend sensor technology and products using its patented Bend Sensor technology. Flexpoint manufactures, and has jointly developed, six products that are being sold and supplied to customers. Flexpoint owns nine patents, including patents on specific devices that use the Bend Sensor. The Company works with various Tier 1 (major) automotive suppliers on a variety of products that are in various stages of development and implementation.

Bend Sensor Technology

Flexpoint owns the patent rights to the Company's Bend Sensor technology through Sensitron, Inc. (Sensitron), a wholly owned subsidiary of the Company. The Bend Sensor is a potentiometer bend sensor product consisting of a coated substrate, such as plastic, that changes electrical conductivity as it is bent in a consistent manner. Electronic systems can connect to this sensor and measure in detail the amount of bending or movement that occurs in a predictable manner. A potentiometer functions through the means of metal contacts swiping or rubbing across a resistive element. Flexpoin�� Bend Sensor potentiometer is a single layer with no mechanical assembly that makes it more reliable and smaller, and lighter in weight.

Automotive Products

Flexpoint has developed comfort seat for automobiles utilizing its patented Bend Sensortechnology and is working with Tier 1 suppliers on development of the seat and various seat related controls. Through a joint development arrangement with a Tier1supplier Flexpoint developed and delivered prototypes of the seat. Automobile manufacture has partnered with a Tier 1 supplier and is in the final stages of evaluating Flexpoint�� patented horn switch to replace their existing technology. The automobile manufacturer is also evaluating the use of the Bend Sensor as a switch to open rear! doors of SUV's and as a seat belt reminder (SBR). While working with various Tier 1 automotive suppliers the Company has developed and tested a SBR sensor that alerts the occupant of an automobile to fasten his/her seatbelt.

Flexpoint is working with multiple manufacturers to replace existing devices in the marketplace with a system superior in performance. Four separate and independent automotive suppliers and OEMs tested the Bend Sensor device for use in pedestrian impact detection device. The tests proved that the Bend Sensor device was able to detect impact with a human leg and in the event of an accident and trigger the desired safety response. Flexpoint has also developed a crash sensor, which is a series of sensors mounted in strategic places on the side and door panels of an automobile to detect an impact, as well as the speed, direction and force of the impact. This allows an onboard computer to deploy side air bags where needed. Using the same concept as the Company's automotive seat belt reminder (SBR), this device monitors cinema theater's paying customers and identifies available seats. Flexpoint has supplied a theater management firm with several prototype sensors, which have undergone extensive testing for this application.

As of December 31, 2012, Flexpoint developed and produced 20 prototype medical beds that assist in the management of bed sores. Using the Bend Sensor technology and accompanying electronics the bed is able to determine the position of the person in the bed and how they are moved. The Company has developed a vibration sensor, a rupture disc/bursting disc utilizing the Bend Sensor as the detection/alarm element of a rupture disc device, an infant bed cover using its patented sensors that is used to monitor infants in the prevention of sudden infant death syndrome (SIDS), toys and video gaming devices, and sports applications.

Advisors' Opinion:

• [By CRWE]

  Today, FLXT has shed (-6.25%) down -0.0060 at $.0900 with 19,500 shares in play thus far (ref. google finance Delayed: 11:10AM EDT September 25, 2013).

  Flexpoint Sensor Systems, Inc. previously reported they expect to complete both Phase Two and Phase Three of development of the colonoscope application during the remainder of 2013. The company will receive milestone cash payments for each stage of the development process.

Top 10 Dow Dividend Stocks To Buy Right Now: Insulet Corporation(PODD)

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.

Advisors' Opinion:

• [By Rich Smith]

  This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of downgrades for document storage company Iron Mountain (NYSE: IRM  ) and insulin treatments-equipment maker Insulet (NASDAQ: PODD  ) . But the headlines aren't all bad, so before we break the bad news to you, let's start off on a bright note about...

Top 10 Dow Dividend Stocks To Buy Right Now: Softbank Corp (SFTBF)

SOFTBANK CORP. is a Japan-based company that provides digital information services. The Company has six business segments. The Mobile Communication segment provides cellular phone services and sells attached cellular phone terminals. The Broadband and Infrastructure segment provides high-speed Internet access services, Internet protocol (IP) phone service, and contents. The Fixed Communication segment provides transmission services for audio and data, as well as exclusive line and data center services. The Internet Culture segment is engaged in the Internet advertising, broadband portal and auction businesses. The Electronic Commerce (E-Commerce) segment sells personal computers (PCs), peripheral devices and software for PC use, as well as provides business-to-business and business-to-customer e-commerce services. The Others segment is involved in the broadcasting media, technology service, media marketing and overseas fund businesses.

Advisors' Opinion:

• [By Sophia Yan]

  Also poised to win big in the Alibaba IPO is Masayoshi Son, Japan's richest man. He is CEO of telecoms group Softbank (SFTBF), which has seen the value of its original $20 million investment soar to about $54 billion.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- With the yen holding on to its gains and investors cautious as earnings season kicks off, Japanese stocks slid lower Friday after closing the previous day with some late-session gains. The Nikkei Stock Average (JP:NIK) fell 0.9% to 14,358.28, with the Topix down 0.8%, as the dollar bought 97.36 yen, little changed from 24 hours earlier. The relatively strong yen weighed on some names with high global exposure, as Sharp Corp. (JP:6753) (SHCAF) lost 1%, Pioneer Corp. (JP:6773) (PNCOF) dropped 1.6%, and Bridgestone Corp. (JP:5108) (BRDCF) fell 1.2%. An outlook cut from Canon Inc. (JP:7751) (CAJ) helped send its shares down 1%, while rival Nikon Corp. (JP:7731) (NINOF) lost 1.8%, though Olympus Corp. (JP:7733) (OCPNF) gained 1%. Telecoms were weak, with Softbank Corp. (JP:9984) (SFTBF) falling 2.5%, KDDI Corp. (JP:9433) (KDDIF) down 1.7%, and NTT DoCoMo Inc. (JP:9437) (NTDMF)

• [By Daniel Inman]

  Shares in Softbank Corp. (JP:9984) � (SFTBF) ���one of the largest constituents on the Nikkei Average ��fell 2.2% after The Wall Street Journal reported that the firm�� Sprint (S) �unit is considering a takeover of its smaller rival T-Mobile US (TMUS) , with a bid potentially coming in the first half of 2014.

• [By Daniel Inman]

  Softbank (JP:9984) � (SFTBF) �rose 2% in Tokyo following a Nikkei report that said the telecoms company�� group operating profit for the first half of the fiscal year likely rose 70% on-year to more than 楼700 billion ($7.13 billion).

Top 10 Dow Dividend Stocks To Buy Right Now: BreitBurn Energy Partners L.P.(BBEP)

BreitBurn Energy Partners L.P. engages in the acquisition, exploitation, and development of oil and gas properties in the United States. The company?s properties include natural gas, oil, and midstream assets comprising fields in the Antrim Shale in Michigan, and the New Albany Shale in Indiana and Kentucky; and fields in the Evanston and Green River basins in southwestern Wyoming, the Wind river and Big Horn basins in central Wyoming, the Powder River basin in eastern Wyoming, the Los Angeles basin in California, and fields in Florida?s Sunniland Trend. As of December 31, 2011, its total estimated proved reserves were 151.1 million barrels of oil equivalent. BreitBurn GP, LLC serves as the general partner to the company. BreitBurn Energy Partners L.P. was founded in 2006 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By Matt DiLallo]

  The first quarter is a notoriously slow one for the oil and gas industry, because the weather really does play a factor. However, the weather this past quarter was worse than most energy companies were expecting. BreitBurn Energy Partners (NASDAQ: BBEP  ) COO Mark Pease pointed to this fact in his remarks on the company's conference call. In talking about its production in Wyoming, he said that lower production at its gas wells was "primarily due to the harsh winter�weather, which increased downtime compared to forecast." He went on to say that the company "typically experienced lower production in the first half of the year for our operations in states with winter�weather�conditions." He continued: "Because of the additional cost of working in the winter season, drilling activity was relatively slow." One thing�was clear in the quarter: While bad weather was anticipated, the weather was worse than anyone projected.�

• [By Robert Rapier]

  The fracking revolution has created enormous opportunities for Master Limited Partnerships (MLPs) across the oil and gas industry. Upstream MLPs like�BreitBurn Energy Partners�(NASDAQ: BBEP) and�Legacy Reserves�(NASDAQ: LGCY) produced the oil and gas. There was a huge new requirement for sand in the fracking operations, and this encouraged new MLPs like�Emerge Energy Services�(NYSE: EMES) and�Hi-Crush Partners�(NYSE:HCLP) — both of which have more than doubled in price over the past 12 months. Fracking also requires large volumes of water, which�Cypress Energy Partners�(NYSE: CELP) provides.

Top 10 Dow Dividend Stocks To Buy Right Now: Petrosonic Energy Inc (PSON)

Petrosonic Energy, Inc, incorporated on June 11, 2008, is a development-stage company. The Company focused on the treatment and upgrading of heavy oil by sonicated solvent de-asphalting. On July 27, 2012, the Company completed the acquisition of 60% ownership in Petrosonic Albania, SHA. from Sonoro.

The Company�� core technology is an industrial scale sonic reactor that transfers sonic energy on an industrial scale to physical, chemical or biological processes. As of December 31, 2012, the Company had not generated any revenue.

Advisors' Opinion:

• [By Inyoung Hwang]

  Pearson (PSON) jumped 6.2 percent to 1,329 pence, the highest price since May 2001. The media and education company said first-half revenue climbed 7 percent to 2.76 billion pounds ($4.3 billion), surpassing the 2.69 billion-pound average prediction of analysts. Profit fell 26 percent as the company invested in new products.

• [By Namitha Jagadeesh]

  Pearson Plc (PSON) surged 6.2 percent to 1,329 pence, its highest price since 2001. The publisher of the Financial Times newspaper posted first-half sales of 2.76 billion pounds ($4.2 billion), exceeding the 2.69 billion pounds estimated by analysts in a Bloomberg survey.

Top 10 Dow Dividend Stocks To Buy Right Now: SMART Technologies Inc.(SMT)

SMART Technologies Inc. designs, develops, and sells interactive technology products and solutions that enhance learning and enable people to collaborate worldwide. The company offers a range of SMART Board interactive whiteboards and displays, as well as other interactive products, such as interactive tables, interactive pen displays, student response systems, wireless slates, audio enhancement systems, document cameras, conferencing software, and a line of interactive learning software. Its portfolio of related attachment products include SMART Response, SMART Slate, SMART Document Camera, SMART Table, SMART Audio, and SMART Classroom Suite. SMART Technologies also provides free online learning resources, an online teacher community, and training and professional development. It sells its interactive whiteboards through a network of distributors and dealers to the education, business, and government markets. The company was founded in 1987 and is headquartered in Calgary , Canada.

Advisors' Opinion:

• [By Seth Jayson]

  Smart Technologies (Nasdaq: SMT  ) is expected to report Q4 earnings on May 16. Here's what Wall Street wants to see:

  The 10-second takeaway
  Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Smart Technologies's revenues will wither -22.4% and EPS will remain in the red.

• [By Michael Robinson]

  Smart Technologies (SMT)

  Smart Technologies is a company that literally lives up to its name. It's a supplier of interactive education tools, used by more than 40 million students, in more than 175 countries.

• [By MONEYMORNING.COM]

  Smart Technologies Inc. (Nasdaq: SMT) is a company that literally lives up to its name. It's a supplier of interactive education tools used by more than 40 million students in more than 175 countries.

Top Industrial Disributor Stocks To Buy For 2015

Top Industrial Disributor Stocks To Buy For 2015: CNOOC Limited(CEO)

CNOOC Limited, through its subsidiaries, engages in the exploration, development, production, and sale of crude oil, natural gas, and other petroleum products. The company?s oil and natural gas properties are located in offshore China, which include Bohai Bay, western south China Sea, eastern south China Sea, and east China Sea, as well as in Indonesia, Iraq, and other regions in Asia; and Oceania, Africa, North America, and South America. As of December 31, 2010, the company had net proved reserves of approximately 2.99 billion barrels-of-oil equivalent, including approximately 1.92 billion barrels of crude oil and 6,458.3 billion cubic feet of natural gas. It also provides bond issuance services; and has a joint venture with Bridas Energy Holdings. CNOOC Limited was founded in 1982. The company is headquartered in Central, Hong Kong, and is considered a Red Chip company due to its listing on the Hong Kong Stock Exchange. CNOOC Limited is a subsidiary of China National Of fshore Oil Corporation.

Advisors' Opinion:

• [By Chris Mydlo]

  CNOOC Ltd. (CEO) is trading at a low P/S ratio of 1.60, near its 10-year low of 1.42. The company explores for, develops, produces, and sells crude oil, natural gas, and other petroleum products. It is held by nine gurus we follow.

• [By Arjun Sreekumar]

  Notable foreign joint ventures
  The practice has been quite common among foreign companies engaging in joint ventures with U.S. firms. For instance, the use of a drilling carry was a feature of Chesapeake Energy's (NYSE: CHK  ) transaction with China's largest energy company, CNOOC (NYSE: CEO  ) , back in 2010, though it was noticeably absent from its most recent joint venture agreement with Sinopec (NYSE: SHI  ) .

• [By Arjun Sreekumar]

  Initially, exploration activity in the Arctic was confined primarily to Western oil majors. ! But recently, the China National Offshore Oil Corporation, better known as CNOOC (NYSE: CEO  ) , became the first Chinese oil company to make a play for Arctic oil. Let's take a closer look at why China has become increasingly interested in the Arctic frontier's vast resource potential.

• [By Jim Jubak]

  The auction news isn't good for investors in Brazil's Petrobras (PBR), but it could well be a boon for China and Chinese oil companies such as PetroChina (PTR) and CNOOC (CEO).

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-industrial-disributor-stocks-to-buy-for-2015-3.html

Top 5 Net Payout Yield Stocks To Invest In Right Now

April is best known for its spring showers. But on Wall Street, it's known as the best-performing month for the Dow Jones industrial average.

Now that the first quarter of 2014 is in the books, with the Dow declining 0.7% in the first three months of the year, investors are hoping that the fourth month of the year lives up to the mega-bullish reputation it has earned over the past 50 years.

April has been the hottest month for the Dow over the past 50 years and 20 years, gaining an average of more than 2% in each time period, says Bespoke Investment Group. April is the only month to post 2%-plus gains.

MARKETS: Stocks end quarter on bullish note

In the past 50 years, the Dow has posted average gains of 2.21%, and finished up for the month nearly two-thirds of the time.

Top Oil Service Companies To Own For 2015: Santos Ltd (STOSF)

Santos Limited is an oil and gas producer, supplying Australian and Asian customers. The Company is primarily engaged in the exploration for, and development, production, transportation and marketing of, hydrocarbons. The Company develops major oil and gas liquids businesses in Australia, and operates in all mainland states and the Northern Territory. The Company has exploration-led Asian portfolio, with a focus on three core countries: Indonesia, Vietnam and Papua New Guinea. The Company operates in four business units of Eastern Australia; Western Australia and Northern Territory; Asia Pacific, and Gladstone LNG (GLNG). The Asia Pacific operating segment includes operations in Indonesia, Papua New Guinea, Vietnam, India and Bangladesh. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australian stocks fell early Wednesday, tracking a weak lead from the U.S. but with a few blue-chip miners higher after gains for some commodities overnight. The S&P/ASX 200 (AU:XJO) retreated 0.4% to 5,237.80 after similar losses for the main Wall Street indexes, with the Australian benchmark trading around its lowest level since October. Among the major decliners, Qantas Airways Ltd. (AU:QAN) (QUBSF) lost 2.5%, Harvey Norman Holdings Ltd. (AU:HVN) (HNORY) gave up 1.3%, and Incitec Pivot Ltd. (AU:IPL) (ICPVY) fell 1.8%. Santos Ltd. (AU:STO) (STOSF) fell 2.6% on indication it will miss its lowered production guidance for 2013, according to the Australian Financial Review. On the upside, top miners BHP Billiton Ltd. (AU:BHP) (BHP) and Rio Tinto Ltd. (AU:RIO) (RIO) rose 0.3% and 0.7%, respectively, while Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) traded 1% higher. Shares of global shopping-mall developer Westfield Group Australia (AU:WDC) (WEFIF) were on halt

Top 5 Net Payout Yield Stocks To Invest In Right Now: VolitionRX Ltd (VNRX)

VolitionRX Limited, formerly Standard Capital Corporation, incorporated on September 24, 1998, through its wholly owned subsidiary Singapore Volition Pte Limited (Volition), is a life sciences company focused on developing blood-based diagnostic tests. As of October 12, 2011, Volition was developing a range of blood-based epigenetic cancer screening tests, which will be released for research then clinical use in Europe, North America and globally. The tests will enable doctors to screen for the general presence of cancer in the body with a single blood test, and investigate, which cancer is present in many of those cancer positive patients using a panel of tests. On October 6, 2011, the Company announced the closure of the share exchange agreement with the Company. On October 6, 2011, Volition became a wholly owned subsidiary of the Company.

Volition�� HyperGenomics technology will determine specific epigenetic signatures from cancer biopsies. The HyperGenomics range of tests will be used as a second line once cancer has been diagnosed, to determine the specific subtype of disease and to help decide the most appropriate therapy. Volition is developing a non-invasive blood test for endometriosis, based on its Nucleosomics technology.

Advisors' Opinion:

• [By Peter Graham]

  At the end of last week, small cap stocks Senesco Technologies, Inc (OTCBB: SNTI), VolitionRX Ltd (OTCMKTS: VNRX) and Micromem Technologies Inc (OTCBB: MMTIF) were all trending upwards ��ending up 13.65%, 8.73% and 7.61%, respectively, on Friday. However, it�� a new trading week with the last two trading days for the year. So what direction will these three small caps head in for the end of this year and into next year? Here is a quick look to help you decide on a trading or investment strategy:

Top 5 Net Payout Yield Stocks To Invest In Right Now: Forest Laboratories Inc (FRX)

Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.

Aclidinium

In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

Linaclotide

Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.

Viibryd

As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.

Daliresp

In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.

Namenda

Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.

Bystolic

Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).

Savella

Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.

Teflaro

In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.

Avibactam

Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.

Lexapro

Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.

Cariprazine

Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.

Levomilnacipran

Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.

GRT 6005

In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.

TTP399

In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.

Azimilide

In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.

RGH-618

RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.

Advisors' Opinion:

• [By Jon C. Ogg]

  Forest Laboratories Inc. (NYSE: FRX) is already closing on one deal, and was shown as having 3 deals under its belt in the last ten years. The Merrill Lynch report here shows that its focus is on primary care products within its current five therapeutic areas: GI, cardiovascular, CNS, respiratory, and infectious disease. They show that Forest is open to deals to replenish the drug pipeline with a high probability of success. Forest is worth more than $17 billion.

• [By Jake L'Ecuyer]

  Top Headline
  Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014.

Top 5 Net Payout Yield Stocks To Invest In Right Now: Biomerieux SA (BIM)

Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, such as bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, bioMerieux Benelux SA/NV, among others. In January 2014, it acquired 100% stake in BioFire Diagnostics Inc. Advisors' Opinion:

• [By Jonathan Morgan]

  BioMerieux (BIM) jumped 3.8 percent to 76.53 euros, the largest gain in eight months. The French maker of tests for HIV and hepatitis reported sales for the first half of 754 million euros and confirmed its revenue-growth forecast.